Search research articles
Contact Us
Filters
Showing results (61-70 of 292) with videos related to
Page
of 30
Sort By:
Drug Design, Development and Therapy
|
February 29, 2020
Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers
Deok Yong Yoon, Sang-In Park, Jin-A Jung, et al.
Alimentary Pharmacology & Therapeutics
|
October 28, 2020
Pharmacodynamics and pharmacokinetics of DWP14012 (fexuprazan) in healthy subjects with different ethnicities
Jun Gi Hwang, Inseung Jeon, Sun Ae Park, et al.
British Journal of Clinical Pharmacology
|
October 13, 2020
Safety, pharmacokinetics and pharmacodynamics of BI 655064 in phase 1 clinical trials in healthy Chinese and Japanese subjects
Yasuhiro Tsuda, Christine Grimaldi, Fenglei Huang, et al.
Translational and Clinical Pharmacology
|
October 8, 2021
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform
Byungwook Kim, Deok Yong Yoon, SeungHwan Lee, et al.
British Journal of Clinical Pharmacology
|
December 10, 2022
Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter 2 inhibitor, with gemigliptin and metformin in healthy adults
Sae Im Jeong, Yun Kim, Jae Jin Nah, et al.
British Journal of Clinical Pharmacology
|
April 23, 2002
Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19
Joo-Youn Cho, Kyung-Sang Yu, In-Jin Jang, et al.
Clinical Pharmacology and Therapeutics
|
September 7, 2017
Identification of ω- or (ω-1)-Hydroxylated Medium-Chain Acylcarnitines as Novel Urinary Biomarkers for CYP3A Activity
Bora Kim, Jieon Lee, Kwang-Hee Shin, et al.
Clinical Therapeutics
|
November 25, 2010
Pharmacokinetic and pharmacodynamic comparison of two recombinant human erythropoietin formulations after single subcutaneous administration: an open-label, sequence-randomized, two-treatment crossover study in healthy Korean male volunteers
Tae-Eun Kim, Kyu-Pyo Kim, Bo-Hyung Kim, et al.
Clinical and Translational Science
|
October 20, 2021
Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non-Japanese
Eunsol Yang, Jung Sunwoo, Ki Young Huh, et al.
Drug Design, Development and Therapy
|
July 8, 2024
Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects
Hyunwook Ryu, Hyun Chul Kim, Inseung Jeon, et al.
Page
of 30
Search research articles
Search
Showing results (61-70 of 292) with videos related to
Sort By:
Page
of 30
Drug Design, Development and Therapy
|
February 29, 2020
Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers
Deok Yong Yoon, Sang-In Park, Jin-A Jung, et al.
Alimentary Pharmacology & Therapeutics
|
October 28, 2020
Pharmacodynamics and pharmacokinetics of DWP14012 (fexuprazan) in healthy subjects with different ethnicities
Jun Gi Hwang, Inseung Jeon, Sun Ae Park, et al.
British Journal of Clinical Pharmacology
|
October 13, 2020
Safety, pharmacokinetics and pharmacodynamics of BI 655064 in phase 1 clinical trials in healthy Chinese and Japanese subjects
Yasuhiro Tsuda, Christine Grimaldi, Fenglei Huang, et al.
Translational and Clinical Pharmacology
|
October 8, 2021
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform
Byungwook Kim, Deok Yong Yoon, SeungHwan Lee, et al.
British Journal of Clinical Pharmacology
|
December 10, 2022
Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter 2 inhibitor, with gemigliptin and metformin in healthy adults
Sae Im Jeong, Yun Kim, Jae Jin Nah, et al.
British Journal of Clinical Pharmacology
|
April 23, 2002
Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19
Joo-Youn Cho, Kyung-Sang Yu, In-Jin Jang, et al.
Clinical Pharmacology and Therapeutics
|
September 7, 2017
Identification of ω- or (ω-1)-Hydroxylated Medium-Chain Acylcarnitines as Novel Urinary Biomarkers for CYP3A Activity
Bora Kim, Jieon Lee, Kwang-Hee Shin, et al.
Clinical Therapeutics
|
November 25, 2010
Pharmacokinetic and pharmacodynamic comparison of two recombinant human erythropoietin formulations after single subcutaneous administration: an open-label, sequence-randomized, two-treatment crossover study in healthy Korean male volunteers
Tae-Eun Kim, Kyu-Pyo Kim, Bo-Hyung Kim, et al.
Clinical and Translational Science
|
October 20, 2021
Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non-Japanese
Eunsol Yang, Jung Sunwoo, Ki Young Huh, et al.
Drug Design, Development and Therapy
|
July 8, 2024
Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects
Hyunwook Ryu, Hyun Chul Kim, Inseung Jeon, et al.
Page
of 30